Next Science Limited's Judith Mitchell speaks with Proactive during the ASX Small and Mid-Cap Conference. The company's primary focus is on the development and continued commercialisation of its proprietary XBIO technology to reduce the impact of biofilm based infections in human health.
Next Science with Proactive at the ASX Small and Mid-Cap Conference
